Ann: MedAdvisor signs $USD3m digital COVID-19 patient program, page-11

  1. 2,482 Posts.
    lightbulb Created with Sketch. 217
    All Covid related announcements must be squeaky clean to get past ASX. Wonder why?

    Yes, I agree Trial to run during Q2 FY22 and to be assessed in Q3. Up to $A4m revenue which is 20% on Q1. Given Covid related and potential 20% uplift in revenue, better a TH than a suspension in my opinion.

    I have held this for several years, Back in FY19/20 when they were doing $2m a quarter $4m was a company making dream. I'm surprised how world weary some of my new co-owners are to this unexpected news. I obviously need to get out a bit more.
 
Add to My Watchlist
What is My Watchlist?
A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.
(20min delay)
Last
6.5¢
Change
0.000(0.00%)
Mkt cap ! $40.64M
Open High Low Value Volume
6.7¢ 6.7¢ 6.5¢ $730 11.07K

Buyers (Bids)

No. Vol. Price($)
2 98000 6.4¢
 

Sellers (Offers)

Price($) Vol. No.
6.5¢ 50406 1
View Market Depth
Last trade - 11.17am 07/08/2025 (20 minute delay) ?
MDR (ASX) Chart
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.